Funder: Alliance for Cancer Gene Therapy

Due Dates: May 16, 2025 (Letter of Intent) | August 22, 2025 (Full Application, by invitation)

Funding Amounts: Up to $500,000 total over 2–3 years (max 10% indirect costs included)

Summary: Supports research on innovative cell and gene therapies for gynecological cancers, targeting ovarian, endometrial, and cervical cancers to improve outcomes for women.

Key Information: Two-step process: LOI required; only invited applicants may submit full proposals.